Jean-Pierre Marie

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

R. Willemze, Stefan Suciu, Giovanna Meloni et al. · Journal of Clinical Oncology · 2013 · 168 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD–mutated, relapsed or refractory AML

Jörge E. Cortes, Martin S. Tallman, Gary J. Schiller et al. · Blood · 2018 · 151 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia

Simona Lapusan, María‐Belén Vídriales, Xavier Thomas et al. · Investigational New Drugs · 2011 · 107 citations

Medicine, Oncology, Pharmacology +16

Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-α expression

Michelina Nascimbeni, Leïla Perié, Laurent Chorro et al. · Blood · 2009 · 75 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Both Pgp and MRP1 Activities Using Calcein-AM Contribute to Drug Resistance in AML

Ollivier Legrand, Ghislaine Simonin, Jean‐Yves Perrot et al. · Advances in experimental medicine and biology · 1999 · 14 citations

Medicine, Biochemistry, Pharmacology +14